Search Results - "Madrid, Manuelito A"

Multicenter Prospective Study in HER2-Positive Early Breast Cancer for Detecting Minimal Residual Disease by Circulating Tumor DNA Analysis With Neoadjuvant Chemotherapy: HARMONY Study by Tokura, Momoko, Ando, Mark Malalay, Kojima, Yuki, Kitadai, Rui, Yazaki, Shu, Atutubo, Cyrielle Marie N, Li, Rubi K., Perez, Minda Z., Gorospe, Agnes E, Madrid, Manuelito A, Ordinario, Mel Valerie C, Imasa, Marcelo Severino B, Sudo, Kazuki, Shimoi, Tatsunori, Suto, Akihiko, Kohsaka, Shinji, Machida, Ryunosuke, Sadachi, Ryo, Yoshida, Masayuki, Yatabe, Yasushi, Hata, Tomomi, Nakamura, Kenichi, Yonemori, Kan, Shiino, Sho

“…Background: Biomarkers to predict the recurrence risk are required to optimize perioperative treatment. Adjuvant chemotherapy for patients with human epidermal…”
Get full text

Chromogenic in situ hybridization (CISH): a novel alternative in screening archival breast cancer tissue samples for HER-2/neu status by Madrid, Manuelito A, Lo, Raymundo W

“…Chromogenic in situ hybridization (CISH) is emerging as a practical, cost-effective, and valid alternative to fluorescent in situ hybridization in testing for…”
Get full text